Summary
We provide a side-by-side analysis of the Lower Drug Costs Now Act (H.R. 3), introduced by House Speaker Nancy Pelosi (D-CA) and House Democrats, and key provisions of relevant proposals: the Prescription Drug Pricing Reduction Act of 2019, advanced by the Senate Finance Committee (19-9) in July; and the Advanced Notice of Proposed Rulemaking: Medicare Program; International Pricing Index Model for Medicare Part B Drugs, issued by the Centers for Medicare and Medicaid Services (CMS) last October.
The chart examines key provisions regarding drug price negotiation, Medicare Part B and D inflation rebates, and redesigning Medicare Part D.